# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Investor webcast on or before July 23 will include updates on Jaguar's cancer supportive care portfolio, including particip...
The drug candidate demonstrates antipsychotic activity and has a mechanism of action distinct from FDA-approved therapies for s...
Jaguar Health shares are falling after the stock effected a reverse split at an exchange ratio of 1-for-60 Thursday, in order t...